BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1768651)

  • 1. DNA CpG methylation inhibits binding of NF-kappa B proteins to the HIV-1 long terminal repeat cognate DNA motifs.
    Bednarik DP; Duckett C; Kim SU; Perez VL; Griffis K; Guenthner PC; Folks TM
    New Biol; 1991 Oct; 3(10):969-76. PubMed ID: 1768651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
    Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
    J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.
    Tong-Starksen SE; Welsh TM; Peterlin BM
    J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-kappa B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-kappa B site and CArG box.
    Suzuki T; Hirai H; Fujisawa J; Fujita T; Yoshida M
    Oncogene; 1993 Sep; 8(9):2391-7. PubMed ID: 8361755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6.
    Kunsch C; Lang RK; Rosen CA; Shannon MF
    J Immunol; 1994 Jul; 153(1):153-64. PubMed ID: 8207232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer.
    Steger DJ; Workman JL
    EMBO J; 1997 May; 16(9):2463-72. PubMed ID: 9171359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
    Madore SJ; Cullen BR
    Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the human immunodeficiency virus type 1 long terminal repeat: interactions of thyroid hormone receptor with retinoid-X receptor, nuclear factor kappa B, Sp1, and Tat.
    Desai-Yajnik V; Samuels HH
    Trans Assoc Am Physicians; 1993; 106():13-32. PubMed ID: 8036737
    [No Abstract]   [Full Text] [Related]  

  • 9. An increase in p50/p65 NF-kB binding to the HIV-1 LTR is not sufficient to increase viral expression in the primary human astrocyte.
    Conant K; Atwood WJ; Traub R; Tornatore C; Major EO
    Virology; 1994 Dec; 205(2):586-90. PubMed ID: 7975262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
    Perkins ND; Edwards NL; Duckett CS; Agranoff AB; Schmid RM; Nabel GJ
    EMBO J; 1993 Sep; 12(9):3551-8. PubMed ID: 8253080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism.
    Okamoto T; Ogiwara H; Hayashi T; Mitsui A; Kawabe T; Yodoi J
    Int Immunol; 1992 Jul; 4(7):811-9. PubMed ID: 1498089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription.
    Kundu M; Guermah M; Roeder RG; Amini S; Khalili K
    J Biol Chem; 1997 Nov; 272(47):29468-74. PubMed ID: 9368006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-RelA transcription factor.
    Hansen SK; Guerrini L; Blasi F
    J Biol Chem; 1994 Sep; 269(35):22230-7. PubMed ID: 8071349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation and retrovirus expression.
    Bednarik DP
    EXS; 1993; 64():300-29. PubMed ID: 8380351
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene products.
    Muchardt C; Seeler JS; Nirula A; Shurland DL; Gaynor RB
    J Virol; 1992 Jan; 66(1):244-50. PubMed ID: 1727488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression.
    Seeler JS; Muchardt C; Suessle A; Gaynor RB
    J Virol; 1994 Feb; 68(2):1002-9. PubMed ID: 8289330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel DNA binding domain-based assays for detection of methylated and nonmethylated DNA.
    Acevedo LG; Sanz A; Jelinek MA
    Epigenomics; 2011 Feb; 3(1):93-101. PubMed ID: 22126156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro.
    Pazin MJ; Sheridan PL; Cannon K; Cao Z; Keck JG; Kadonaga JT; Jones KA
    Genes Dev; 1996 Jan; 10(1):37-49. PubMed ID: 8557193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETS family proteins activate transcription from HIV-1 long terminal repeat.
    Seth A; Hodge DR; Thompson DM; Robinson L; Panayiotakis A; Watson DK; Papas TS
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1017-23. PubMed ID: 8280476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.